Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma-Reference-Cited by-同舟云学术

Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma

Published:2015-06 Issue:5 Volume:38 Page:197-210
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Müller Nadja,Michen Susanne,Tietze Stefanie,Töpfer Katrin,Schulte Alexander,Lamszus Katrin,Schmitz Marc,Schackert Gabriele,Pastan Ira,Temme Achim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference17 articles.

1. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.;Jena;Blood,2010

2. Natural killer cells, viruses and cancer.;Cerwenka;Nat Rev Immunol,2001

3. Natural killer cell memory.;Paust;Nat Immunol,2011

4. Up on the tightrope: natural killer cell activation and inhibition.;Lanier;Nat Immunol,2008

5. Natural killer cell recognition of HLA class I molecules.;Brooks;Rev Immunogenet,2000

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming natural killer cells for cancer therapy;Molecular Therapy;2024-09

2. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

3. Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy;Frontiers in Immunology;2024-08-30

4. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

5. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements;Cancer Biomarkers;2024-08-04